Best 510k software

Overview

If you run regulatory affairs at a medical device company, the search term "510k software" returns a surprisingly mixed market. Purpose-built submission platforms sit next to consulting firms, eCTD publishing tools built for pharma, and FDA guidance pages about when a software change triggers a new 510(k). This guide sorts that out for a specific buyer: a mid-market device manufacturer with a dedicated regulatory and quality team (roughly 10 people) preparing several Class II 510(k) submissions and software-change assessments each year, in-house, without handing every filing to consultants.

This is a compact market. After screening for tools that directly support regulatory submission preparation, validation, and document control, we found four options worth evaluating alongside our featured pick: Certara GlobalSubmit, JJCC Group, Ennov Regulatory Solutions, and Veeva Vault Submissions. That is the honest shape of this shortlist, not a curated cut from a longer list. Public evidence varies widely across these vendors, and we flag where documentation is thin rather than paper over it.

One pattern to know before you read further: none of the vendors in this market publishes pricing. Every option here is quote-based, so the comparison comes down to workflow coverage, validation depth, compliance controls, and how much you can verify before a sales call.

For the buyer scenario above, Assyro is the strongest fit. It combines a shared submission workspace, continuous validation from first draft to final lock, 21 CFR Part 11 controls, and named integrations with SharePoint, Box, and Google Drive, and it publishes more verifiable capability detail than any other vendor on this list.

Featured Option

Assyro

Best for: Regulatory teams in pharma, biotech, and medical devices that want to prepare, validate, and track submissions in one shared workspace instead of stitching together authoring tools, validators, and file shares.

Assyro is AI regulatory submission software built around a single idea: submission documents should be authored, reviewed, and validated in their final structure from day one. Per Assyro's document management and submission management pages, every document is authored in its CTD location from the first draft, with publish-ready structure. There is no Word-to-PDF conversion step, no bookmark rebuilding, and no cross-reference repair at the end of the cycle.

What stands out:

• Continuous validation, not end-stage validation. Assyro runs eCTD v4.0.0 sequence-structure validation from first draft to final lock, in-browser across Modules 1-5, without server file uploads. A decision-tree validation engine checks content-level regulatory logic: cross-module reference consistency between Module 2 summaries and Module 3 data, evidence-to-claim gap detection, missing component detection, and outdated summary flags.
• Remediation with owners attached. Validation findings surface as prioritized items with auto-assigned owners and fix instructions, and the complete validation history is retained for inspection-ready traceability.
• Shared content library. Identical content (a Module 1.12.1 cover letter, a Module 2.2 introduction, standard quality statements) propagates across submissions with approval tracking preserved.
• Review coordination at scale. For large filings, Assyro supports role-based section ownership, review routing, and approval gates, documented for cases such as a complete NDA with 15+ writers across 5 modules.
• Traceability without rebuilding the trail. For any leaf in a submission, the origin document, author, approval timestamp, and change history are retrievable automatically. For a device team maintaining audit-ready traceability across multiple 510(k) cycles and software-change assessments, this source-to-submission linkage is the capability that saves the most rework.

Compliance and admin controls: 21 CFR Part 11 controls, EU Annex 11 aligned workflows, role-based access with approval gates, audit trails with traceable decisions linked to submission evidence, and a redacted QA summary export for internal quality review.

Integrations: SharePoint, Box, and Google Drive for file and document ingestion. Ask the Assyro team about additional integrations, including SSO and provisioning specifics.

Format coverage: FDA (NDA, BLA, IND, ANDA, supplements), EMA MAA, Health Canada, ICH CTD/eCTD v4.0.0, region-specific Module 1 handling for US, EU, and ex-US filings, and PMDA validation criteria.

Pricing: Custom annual quote, scoped to team size, workflow mix, and rollout scope. A 10-seat regulatory team falls in Assyro's 6-15 person qualification band, and pilots are scoped smaller than full deployments. Assyro's pricing page states the platform cuts cost per FDA submission and saves 6+ weeks of timeline per submission. Free browser-based utilities, including an eCTD Validator, a PDUFA calendar, and FDA reference tools, let you test the validation approach before a sales conversation.

Next step: Book a regulatory submission workflow demo to scope a pilot against your current 510(k) cycle.

Shortlist of the Best 510k software

1. Assyro (Featured) — Shared submission workspace with continuous eCTD validation, 21 CFR Part 11 controls, and SharePoint, Box, and Google Drive ingestion for in-house regulatory teams.

2. Certara GlobalSubmit — Cloud eCTD publishing, validation, and review platform with 1.5M+ submissions processed; strongest for pharma-format filings (IND/NDA/ANDA/BLA/MAA) across many global health authorities.

3. JJCC Group — FDA regulatory consulting firm, not software; consultant-led 510(k) preparation, ISO 13485 consulting, mock inspections, and Form 483 resolution.

4. Ennov Regulatory Solutions — Regulatory affairs software suite; limited public documentation is available for independent evaluation.

5. Veeva Vault Submissions — Submissions module within Veeva Vault RIM; limited public documentation was retained for independent evaluation in this guide.

How We Chose

We evaluated each option qualitatively against the criteria that matter most for a device team preparing multiple 510(k) submissions per year:

• 510(k) and eSTAR submission coverage: does the tool directly support device submission formats, or is it built around pharma eCTD structures?
• Submission validation and readiness checks: can defects be caught continuously during drafting, or only at a final publishing gate?
• Predicate research and FDA reference data: does the vendor provide FDA reference tooling that supports substantial equivalence work?
• Document version control and traceability: can you retrieve the origin, author, approval timestamp, and change history for any submitted document?
• 21 CFR Part 11 audit trail and compliance: are electronic records and signatures controls documented?
• Pricing transparency and rollout speed: how much can you learn and budget before a sales cycle?

Evidence came from official product and pricing pages, structured competitor editorial pages, and public G2 and Capterra signals where they exist. We prioritized direct product evidence over directory popularity.

Two scope notes for honesty. First, this shortlist reflects the options with sufficient evaluable evidence in this market, not the entire universe of regulatory software vendors; several other names in the broader regulatory space (LORENZ, EXTEDO, Rimsys, Essenvia, Greenlight Guru, and others) were not researched to the same depth and are not ranked here. Second, this keyword pulls in adjacent categories, so we excluded quality management systems, clinical trial tools, and guidance-only pages that share the keyword but solve a different problem. Those appear in the adjacent options section instead.

Comparison Table

Detailed Reviews

1. Certara GlobalSubmit

Fit: Certara GlobalSubmit is a cloud eCTD platform for publishing, validating, reviewing, and transmitting submissions across the full lifecycle. Per Certara's product pages, it has processed over 1.5 million regulatory submissions over 15+ years. Its center of gravity is pharma and biotech: the listed submission types are IND, NDA, ANDA, sNDA, BLA, MAA, DMF, ASMF, and NDS.

Standout capabilities:

• Live validation during publishing that identifies and corrects errors in real time, with no separate validation tool required.
• Automatic CrossCheck QC of hyperlinks and bookmarks, up to 8x faster and 3x more accurate than manual methods per Certara, plus automated hyperlink creation and health-authority-compliant PDF generation.
• The ability to publish only revised sections instead of regenerating an entire submission.
• GlobalSubmit REVIEW, an eCTD viewer with annotation and multi-stakeholder approval workflows.
• eCTD 3.2.2, eCTD 4.0 (developed with direct FDA input, among the first to support FDA eCTD 4.0), and NeeS support.
• Health authority coverage spanning FDA, EMA, Health Canada, Swissmedic, TGA, PMDA, NMPA, SAHPRA, the GCC, and ANVISA (Brazil) via a Certara-ANVISA partnership.

Compliance and integrations: 21 CFR Part 11 compliance is confirmed in the REVIEW page FAQ, backed by an ISO 27001-certified ISMS. Integrations include the FDA Electronic Submissions Gateway (ESG/ESG NextGen), Certara's own Pinnacle 21 and CoAuthor, and "leading eDMS platforms," which Certara does not name specifically.

Pricing: Quote-based. No tiers, dollar amounts, free trial, or free plan are published anywhere on certara.com; the calls to action are "Schedule a demo" and "Contact us." A 10-seat team running 4 submissions per year cannot compute a budget from public sources.

Review signals: Public review data is extremely thin. G2 hosts an unclaimed GlobalSubmit profile showing 4.5/5 from a single review. That lone G2 reviewer praises how easy it is to review health authority submissions across sequences and calls the interface intuitive with built-in templates, but reports the software is sometimes very slow and conflicts with Adobe PDF. Nothing substantive was found on Capterra, Software Advice, or RAPS forums.

Tradeoffs: No native 510(k)/eSTAR support. The supported submission types are pharma-centric, so a device team preparing four 510(k) filings per year would still need separate eSTAR assembly and predicate-research tooling. The unnamed eDMS integrations also make it hard to verify fit with your existing document stack before a demo.

Bottom line: The most proven high-volume eCTD publishing engine on this list, and the right call if your filings are IND/NDA/BLA-format across many authorities. It does not solve the 510(k)-specific parts of the device buyer's job.

2. JJCC Group

Fit: JJCC Group is an FDA regulatory consulting firm, not a software platform. Per jjccgroup.org, it offers hands-on compliance services across pharmaceuticals, medical devices, dietary supplements, tobacco/vape, and food and beverage, citing 30+ years of FDA compliance experience. It appears in this market because it explicitly sells 510(k) submission services, and because its buyer's-guide content ranks for software queries.

Standout capabilities (consultant-delivered):

• 510(k) submission preparation for medical devices, listed alongside QMS, CAPA, FDA mock inspection, and FDA Warning Letter (Form 483) resolution services.
• ISO 13485 consulting grounded in FDA 21 CFR Part 820, EU MDR, MDSAP, and harmonized international requirements, covering implementation, internal audits, supplier qualification, CAPA management, and post-market surveillance.
• ISO 9001:2015 consulting spanning gap analysis, documentation development, internal audits, and certification readiness.
• A multi-industry bench with access to scientists, toxicologists, medical writers, and quality professionals under one engagement.

Compliance and integrations: As a services firm, JJCC does not publish software admin controls, and no integrations were retained in our research, so integration depth cannot be assessed.

Pricing: Quote-based consulting. No tiers, plans, or dollar figures appear on the site; engagement starts via a "Schedule Appointment" link, a contact form, or phone at 1 (800) 999-7781. For the 10-seat / 4-submissions scenario, expect a custom scoped proposal per submission or a retainer.

Review signals: No public ratings or review counts were found for JJCC Group, so third-party sentiment cannot be assessed.

Tradeoffs: Not a software product. There is no 510(k)/eSTAR assembly tool, eCTD validator, document version control system, or 21 CFR Part 11 audit trail; everything is delivered as human consulting services, so a 10-seat regulatory team gets no self-serve workflow platform. Also note that the "eCTD publishing software guide" URL that surfaces in search is a blog post reviewing other vendors' software, not a JJCC product page.

Bottom line: A legitimate option for a small device maker without regulatory staff that wants a consultant to run the 510(k) and QMS work. It solves a staffing problem, not a tooling problem.

3. Ennov Regulatory Solutions

Fit: Ennov positions its offering as regulatory affairs software on its business solutions page. Beyond that positioning, limited public documentation was retained for independent evaluation in this guide, so we cannot verify feature depth, submission format coverage, or compliance controls from the evidence available.

What we can say: Ennov is a known name in the regulatory information management space and appears on buyer radars for regulatory affairs suites. What we could not verify from public materials: specific 510(k) or eSTAR coverage, validation capabilities, named integrations, admin controls, or audit trail documentation.

Pricing: Not published. Budget requires a sales conversation, and no scenario estimate can be constructed for a 10-seat / 4-submissions-per-year team.

Review signals: No public ratings or review counts were retained for this evaluation.

Tradeoffs: The main tradeoff is evaluability. Compared with vendors that publish capability detail (Assyro's module-level validation documentation, Certara's published submission-type lists), Ennov requires a feature-level demo before you can even establish comparable evidence for a shortlist decision.

Bottom line: Potentially relevant for teams evaluating broader regulatory affairs suites, but you should request a demo covering 510(k)/eSTAR support, validation, Part 11 controls, and integrations before treating it as comparable to the documented options here.

4. Veeva Vault Submissions

Fit: Veeva Vault Submissions is the submissions module within Veeva Vault RIM, per veeva.com. As with Ennov, limited public documentation was retained for independent evaluation in this guide, so feature-level claims about validation depth, 510(k)/eSTAR handling, or integrations would not be evidence-based here.

What we can say: Veeva is widely recognized in life sciences software, and Vault Submissions sits inside a larger RIM platform. What we could not verify from the evidence available: specific device submission workflows, validation and readiness checks, named integrations, or documented pricing structure.

Pricing: Not published. No per-seat or per-submission rates were retained, so no estimate exists for the 10-seat / 4-submissions-per-year scenario.

Review signals: No public ratings or review counts were retained for this evaluation.

Tradeoffs: The evaluability gap again. Buyers considering Vault Submissions should gather feature and pricing detail through a sales conversation to reach parity with the documented vendors on this list. For a 200-person device manufacturer, it is also worth asking whether a full RIM platform matches the scope of a focused 510(k) workflow need.

Bottom line: A credible enterprise name that requires direct vendor engagement to evaluate. Shortlist it if you are standardizing on Veeva Vault across regulatory operations; verify device-specific fit before committing.

How to Choose the Right 510k software

Work through these filters in order.

Filter 1: Software or services? If you have no in-house regulatory staff, a consulting engagement with a firm like JJCC Group may be the fastest path to a filed 510(k). If you have a dedicated team (the 10-person scenario this guide anchors on), buy tooling, not consultants. Assyro is the default here: it is built for in-house teams running drafting, validation, review routing, and readiness tracking themselves.

Filter 2: What formats do you actually file? If your volume is pharma-format eCTD (IND, NDA, ANDA, BLA, MAA) across many health authorities, Certara GlobalSubmit's publishing engine, FDA ESG transmission, and eCTD 4.0 support are the strongest documented fit. If your work spans device and pharma-adjacent filings and you need validation and document control across CTD/eCTD structures with FDA, EMA, Health Canada, and PMDA coverage, Assyro covers that range in one workspace.

Filter 3: Where does validation happen in your cycle? If defects surface only at final publishing, you pay for them in rework. Assyro's continuous validation from first draft to final lock, with prioritized remediation and auto-assigned owners, is the strongest documented answer to this question on the list. Certara's live validation during publishing is the alternative model, catching errors at the publishing stage rather than during drafting.

Filter 4: Can you verify Part 11 and traceability before buying? Assyro documents 21 CFR Part 11 controls, EU Annex 11 alignment, audit trails, and automatic source-to-submission lineage. Certara confirms Part 11 compliance and holds ISO 27001 certification. Ennov and Veeva require direct vendor confirmation on these points.

Filter 5: How much rollout risk can you carry? All vendors here are quote-based, so rollout speed becomes the differentiator you can control. Assyro scopes pilots smaller than full deployments and offers free browser-based utilities (including its eCTD Validator) to test before contracting, which lowers the cost of a wrong decision.

Decision checklist:

• [ ] Confirm the vendor supports your actual submission formats, including 510(k)/eSTAR if you are a device team
• [ ] Ask where validation runs: during drafting, at publishing, or both
• [ ] Verify 21 CFR Part 11 controls and audit trail documentation in writing
• [ ] Test document ingestion against your existing stores (SharePoint, Box, Google Drive, or your eDMS)
• [ ] Request a pilot scope and timeline before committing to a full deployment
• [ ] Get the quote normalized to your seat count and annual submission volume

Key Features to Look For in 510k software

Continuous validation, not gate-check validation. The costliest defects are the ones found the week before filing. Look for validation that runs while documents are drafted. Assyro's decision-tree engine checks cross-module reference consistency, evidence-to-claim gaps, missing components, and outdated summaries throughout the cycle, and keeps the full validation history for inspections.

In-structure authoring. If writers draft in Word and a publishing team rebuilds structure at the end, every review cycle multiplies rework. Assyro's in-place CTD authoring, where each document lives in its submission location from draft one, removes the conversion-and-repair step entirely.

Traceability you can retrieve on demand. An FDA inspector or internal auditor will ask where a piece of submitted evidence came from. The checkpoint: can you pull origin document, author, approval timestamp, and change history for any leaf without reconstructing it? Assyro documents exactly this linkage.

Documented Part 11 and Annex 11 controls. Do not accept "compliant" as a one-word answer. Ask for the specifics: role-based access, approval gates, audit trails tied to submission evidence. Assyro and Certara both document their positions publicly; require the same in writing from any vendor that does not.

Named integrations with your document stores. Generic claims like "integrates with leading eDMS platforms" (Certara's phrasing) are unverifiable pre-demo. Assyro names SharePoint, Box, and Google Drive for ingestion; ask the Assyro team about additional integrations relevant to your stack.

FDA reference data at hand. Predicate and equivalence work goes faster when FDA reference tooling sits next to the submission workspace. Assyro publishes free FDA-focused tools, including Orange Book lookups and an eCTD validator, alongside the platform.

Reusable approved content. Cover letters, introductions, and standard quality statements recur across filings. A shared content library that propagates identical content with approval tracking preserved, as Assyro's does, cuts duplicate review cycles across your four-per-year submission cadence.

Pricing and Cost Considerations

Every vendor on this list is quote-based. That is the single most important pricing fact in this market: no one publishes tiers, per-seat rates, or per-submission fees, so budgeting requires sales conversations across the board. What differs is how much scoping structure and pre-sale utility each vendor gives you.

Normalized to the buyer scenario of 10 regulatory seats and 4 submissions per year:

A few cost dynamics to weigh:

• Assyro's scoping is the most transparent process on the list. Its pricing page describes how quotes are built (team-size bands, workflows in scope, rollout plan) and states that pilots are scoped smaller than full deployments. It also claims a cost reduction per FDA submission and 6+ weeks of timeline saved per submission, which is the metric to pressure-test in your demo against your current cycle times.
• Modular platforms can carry hidden scope. Certara's PUBLISH, REVIEW, VALIDATE, and WebReview modules are not individually priced anywhere public, so per third-party analysis, buyers cannot tell whether they are bundled or à la carte without a sales conversation. Ask explicitly.
• Consulting costs scale with volume differently. Software licensing is roughly fixed across your four annual submissions; per-engagement consulting like JJCC's scales linearly with each filing, which changes the math as your pipeline grows.
• Free utilities lower evaluation cost. Assyro's free browser tools (eCTD Validator, PDUFA calendar, FDA Purple Book pages, ROI calculator) let your team test the validation approach before any contract, which no other vendor on this list offers.

Adjacent Options in the 510k software Landscape

These tools and resources overlap with the keyword but solve a different workflow. They are listed neutrally, not ranked.

• FDA guidance ("Deciding When to Submit a 510(k) for a Software Change to an Existing Device") — the primary-source decision framework for software-change assessments; a reference document, not a tool.
• MasterControl — quality management software with a 510(k) submissions angle; its core workflow is QMS document control rather than submission publishing.
• Cruxi — positions itself as a consultant alternative for 510(k) work; its public pages are oriented to that framing rather than a documented submission platform.
• Proxima CRO — a contract research organization with FAQ content on Special 510(k) eligibility; a services and advisory resource.
• I3C Global — consulting content on software medical device documentation for 510(k) submissions.
• eCTDTool — an eCTD software tool for global eCTD submissions; oriented to pharma dossier formats rather than device 510(k) workflows.
• SafetyCulture (and similar FDA compliance apps) — inspection and compliance checklist software, a different job than submission assembly and validation.

Assyro vs Other Options

Assyro vs Certara GlobalSubmit

Both are quote-only, but Certara GlobalSubmit differentiates on scale and reach: 1.5M+ submissions processed over 15+ years, direct FDA Electronic Submissions Gateway transmission, CrossCheck hyperlink QC up to 8x faster than manual methods, and health authority coverage spanning Swissmedic, TGA, PMDA, NMPA, and SAHPRA. Assyro counters with in-place CTD authoring, a shared content library, and named SharePoint, Box, and Google Drive integrations, where GlobalSubmit names its eDMS integrations only generically. Choose Certara GlobalSubmit for high-volume multi-authority eCTD publishing and transmission; choose Assyro for collaborative drafting-through-validation workflows tied to your existing cloud file stores.

Assyro vs JJCC Group

This is a software-versus-services choice. JJCC Group is an FDA regulatory consulting firm delivering hands-on 510(k) preparation, ISO 13485 consulting, and Form 483 resolution, with no eCTD validator, version control, or Part 11 audit trail tooling of its own. Choose JJCC Group when a small device maker lacks regulatory staff and wants outsourced 510(k) and QMS work; choose Assyro when a dedicated team of 6-15 people runs submissions internally and needs tooling, not consultants.

Assyro vs Ennov Regulatory Solutions

Public evidence on Ennov Regulatory Solutions is limited to its regulatory affairs software positioning, with no published feature, integration, or pricing detail retained for this guide, so a substantive head-to-head is not possible from public materials. Assyro documents concrete capabilities (in-browser eCTD v4.0.0 validation, SharePoint/Box/Google Drive ingestion, 21 CFR Part 11 controls), though both require sales contact for pricing. Assyro wins for buyers who need verifiable capability evidence before a demo; request a feature-level demo from Ennov before treating the two as comparable.

Assyro vs Veeva Vault Submissions

Public evidence for Veeva Vault Submissions in this guide is limited to its position as the submissions module in Vault RIM, with no documented features, pricing, or integrations retained, which prevents an evidence-based comparison. Assyro publishes verifiable specifics: pre-configured IND, NDA, BLA, and ANDA sequence templates, decision-tree validation across Modules 1-5, and named cloud storage connectors. Assyro wins for a mid-market team that wants to evaluate against documented capabilities; Veeva is worth a sales conversation if you are standardizing on Vault RIM across a larger regulatory organization.

FAQ

Does eCTD software cover 510(k) submissions?

Not automatically. Certara GlobalSubmit, for example, lists pharma-format submission types (IND, NDA, ANDA, BLA, MAA, DMF, ASMF, NDS) and no native 510(k)/eSTAR support, per its own product pages. If you are a device team, confirm 510(k) and eSTAR handling explicitly before shortlisting any eCTD platform, and ask how the vendor supports device-specific structures rather than assuming CTD coverage transfers.

How much does 510(k) software cost for a 10-person team?

No vendor on this list publishes pricing, so there is no honest public number. Assyro scopes annual contracts by team size, workflow mix, and rollout scope (a 10-seat team falls in its 6-15 person band); Certara sells via demo and quote; JJCC prices per consulting engagement. Budget planning in this market means running two or three quote processes in parallel with the same normalized scenario, such as 10 seats and 4 submissions per year.

When does a software change require a new 510(k)?

FDA's guidance "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" defines the decision framework, including questions about new risks, changes to clinical functionality, and intended use modifications. Software cannot replace that regulatory judgment, but tooling helps you document it: Assyro's audit trails and source-to-submission linkage give you a retrievable record of what changed, who approved it, and when, which is the evidence base a letter-to-file rationale rests on.

Should we buy software or hire a consultant for our next 510(k)?

It depends on staffing, not preference. If no one on your team has run a 510(k), a consulting firm like JJCC Group gets you to a filed submission while you build capability. If you have a dedicated regulatory and quality team, software pays back across every subsequent filing, because validation history, approved reusable content, and traceability compound with each submission cycle.

Can we evaluate any of these tools before a sales call?

Only partially, and Assyro offers the most. Its free browser-based eCTD Validator and FDA reference tools (Orange Book lookups, PDUFA calendar) are usable without a contract. Certara, Ennov, and Veeva require demos for any hands-on evaluation, and JJCC is a services engagement from the first conversation.

Conclusion

This is a small market with clearly differentiated options, and the right choice maps directly to how your team works. For the primary scenario in this guide, a mid-market device manufacturer with a 10-person regulatory and quality team running multiple 510(k) cycles in-house, Assyro is the default recommendation: it documents continuous validation from first draft to final lock, in-place CTD authoring, 21 CFR Part 11 controls, and named SharePoint, Box, and Google Drive integrations, and its free validator tools let you test the approach before you buy.

The alternatives fit narrower situations. Certara GlobalSubmit is the stronger choice for pharma and biotech teams publishing high volumes of eCTD-format submissions to many global health authorities with direct FDA gateway transmission. JJCC Group fits device makers with no in-house regulatory staff who want the entire 510(k) done by consultants. Ennov Regulatory Solutions and Veeva Vault Submissions may suit teams evaluating broader regulatory suites, but both require direct vendor engagement to reach the evidence level the documented options already provide.

Practical next step: normalize every quote to your actual scenario (seats and annual submission volume), verify Part 11 and format coverage in writing, and run a scoped pilot before a full deployment. To start with the documented option, book a regulatory submission workflow demo with Assyro.